Abstract
Thymomas are common mediastinal lesions, especially in association with myasthenia gravis. Here we report a material of 67 patients treated for thymoma. The incidence of myasthenia gravis was 43%. There was no difference in relapse-free survival for patients with or without myasthenia gravis, nor taken into concideration autoimmune diseases in general. Twenty-seven per cent had no symptoms of their tumor and this group fared better regarding relapse-free survival during a follow-up of nine years. There was no significant difference regarding survival neither for age, nor sex, however a significant difference was noted in relation to stage I–IV. Eighty-two per cent were macroscopically radically resected and 28% had some kind of further treatment, and in the latter group survival was significantly lower.
The patients are followed up to ten years. Twenty-one patients have passed away. Forty-five patients are alive with no evidence of disease. One patient is alive with disease.
Thymomas are often malignant (about 25%), but they rarely metastasize. Their malignant potential is demonstrated by a direct invasion of the lung, pericardium, blood vessels, and lymphatics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lattes R.; Thymoma and other types of tumor of the thymus, an analysis of 107 cases.; Cancer 15:1224–1260,1962.
Marino M, Müller-Hermelink HK; Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus.; Virchows Arch A Pathol Anat Histopathol. 407:119–49,1985.
Masaoka et al.; Follow-up study of thymomas with specal reference to their clinical stages.; Cancer 48: 2485–2492, 1981.
Kirchner T, Müller-Hermelink HK; New approaches to the diagnosis of thymic epithelial tumors.; Prog Surg Pathol 10:167–189, 1989.
Kirchner T et al.; Well differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 16: 1153–1169, 1992
Ryback LP.; Metastatic thymoma to the head and neck.; Laryngoscope 98:418–421, 1988.
Batata M.A. et al.; Thymomas: Clinicopathological Features, Therapy and prognosis.; Cancer, 34:389–396, 1974.
Wick M R et al.; Primary Thymic Carcinomas.; Am J. Surg. Pathol, &:229-242,1982.
Monden Y et al.; Recurrence of thymoma: Clinicopathological features, Therapy and Prognosis.; The Annals of Thoracic Surgery, 39, 2, 165–169, 1985.
Arrigada R et al.; Invasive carcinoma of thymus. A multicenter retrospective review of 56 cases.; Eur, J Cancer 20:69–74, 1984.
Uematsu M et al.; A proposal of treatment of invasive thymoma.; Cancer 58:1979–1984, 1986.
Arakawa A et al.; Radiation therapy of invasive thymoma.; Int. J. Radiat. Oncol, Biol. Phys. 18:529–534, 1990.
Daugaard G et al.; Combination therapy for malignant thymoma.; Ann Intern. Med. 998:189–190, 1983.
Daugaard G.; the effect of chemotherapy in the treatment of malignant thymoma.; In Sarrzin, Vrousos, Vincent (eds.): Thymic Tumors, Karger Basel 1989, pp 112-119.
Loehrer Pj et al.; Chemotherapy for advanced thymoma. Preliminary results of an intergroup study.; Ann, Intern. Med. 113:520–524, 1990.
Fornasiero A et al.; Chemotherapy of invasive thymoma.; J. Clin. Oncol. 8:1419–1423, 1990.
Ewans W.K, etal.; Combination chemotherapy in invasive thymoma. Role of COPP.; Cancer 46:1523–1527, 1980.
Tseng-Tong Kuo et al.; Thymoma: a study of the pathology classification of 71 cases with evaluation of the Müller-Hermelink system; Human Pathology vol. 247:766–778, 1993.
Quintanilla-Martinez L, etal.; Thymoma — morphologic sub classification correlates with invasiveness and immunohistologic features: a study of 122 cases; Human Pathology vol. 249:958–969, 1993.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Friström, K., Cervin, A., Enoksson, J.P., Albertsson, M., Johansson, L. (1997). Thymoma—Prognostic Factors and Outcome. In: Marx, A., Müller-Hermelink, H.K. (eds) Epithelial Tumors of the Thymus. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0033-3_46
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0033-3_46
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0035-7
Online ISBN: 978-1-4899-0033-3
eBook Packages: Springer Book Archive